Adult spiral ganglion cells were cultured in chorus to assess the influence of the neurotrophins brain-derived neurotrophic factor, neurotrophin 3 and glial cell line-derived neurotrophic factor (GDNF) on neurite growth and Schwann cell alignment. Over 1500 measurements were collected using each factor at 10 ng/ml and all three in combination. Evaluation was made with GDNF at concentrations of up to 100 ng/ml. Neurite dimensions were assessed at days 5, 7, 9 and 11 using a computer-based program (Axon Analyzer). GDNF had a strong effect on spiral ganglion cell growth almost attaining the level of all three factors in combination. GDNF increased glial cell alignment and nerve bundle formation. Results show the potential of GDNF to maintain and possibly restore auditory nerve integrity.

Keywords:
Neurotrophins, Glial cell line-derived neurotrophic factor, Spiral ganglion, Myelination
1.
Airaksinen MS, Saarma M: The GDNF family: signaling, biological functions and therapeutic value. Nat Rev Neurosci 2002;3:383–394.
2.
Anderson M, Boström M, Pfaller K, Glueckert R, Schrott-Fischer A, Gerdin B, Rask-Andersen H: Structure and locomotion of adult in vitro regenerated spiral ganglion growth cones – A study using video microscopy and SEM. Hear Res 2006;215:97–107.
3.
Boström M, Anderson M, Lindholm D, Park KH, Schrott-Fischer A, Pfaller K, Glueckert R, Gerdin B, Rask-Andersen H: Neural network and ‘ganglion’ formations in vitro: a video microscopy and scanning electron microscopy study on adult cultured spiral ganglion cells. Otol Neurotol 2007;28:1109–1119.
4.
Boström H, Lundström T: Computer-Based Morphometric Assessment of Spiral Ganglion Neurite Outgrowth in vitro Using Image Processing. Centre for Image Analysis Master Thesis No 64, Uppsala University School of Engineering, UPTEC IT04-001, 2004.
5.
Ernfors P, Merlio JP, Persson H: Cells expressing mRNA for neurotrophins and their receptors during embryonic rat development. Eur J Neurosci 1992;4:1140–1158.
6.
Fayad JN, Linthicum FH Jr: Multichannel cochlear implants: relation of histopathology to performance. Laryngoscope 2006;116:1310–1320.
7.
Feng L, Wang CY, Jiang H, Oho C, Mizuno K, Dugich-Djordjevic M, Lu B: Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons. Brain Res Mol Brain Res 1999;66:62–70.
8.
Fritzsch B, Silos-Santiago II, Bianchi LM, Farinas II: Effects of neurotrophin and neurotrophin receptor disruption on the afferent inner ear innervation. Semin Cell Dev Biol 1997;8:277–284.
9.
Garcia-Martinez JM, Perez-Navarro E, Gavalda N, Alberch J: Glial cell line-derived neurotrophic factor promotes the arborization of cultured striatal neurons through the p42/p44 mitogen-activated protein kinase pathway. J Neurosci Res 2006;83:68–79.
10.
Gillespie LN, Shepherd RK: Clinical application of neurotrophic factors: the potential for primary auditory neuron protection. Eur J Neurosci 2005;22:2123–2133.
11.
Glueckert R, Bitsche M, Miller JM, Zhu Y, Prieskorn DM, Altschuler RA, Schrott-Fischer A: Deafferentation-associated changes in afferent and efferent processes in the guinea pig cochlea and afferent regeneration with chronic intrascalar brain-derived neurotrophic factor and acidic fibroblast growth factor. J Comp Neurol 2008;507:1602–1621.
12.
Hansen MR, Vijapurkar U, Koland JG, Green SH: Reciprocal signaling between spiral ganglion neurons and Schwann cells involves neuregulin and neurotrophins. Hear Res 2001a;167:110–121.
13.
Hansen MR, Zha XM, Bok J, Green SH: Multiple distinct signal pathways, including an autocrine neurotrophic mechanism, contribute to the survival-promoting effect of depolarization on spiral ganglion neurons in vitro. J Neurosci 2001b;21:2256–2267.
14.
Hegarty JL, Kay AR, Green SH: Trophic support of cultured spiral ganglion neurons by depolarization exceeds and is additive with that by neurotrophins or cAMP and requires elevation of [Ca2+](i) within a set range. J Neurosci 1997;17:1959–1970.
15.
Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C, Armanini M, Simmons L, Moffet B, Vandlen RA, Simpson LC: GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 1994;266:1062–1064.
16.
Höke A, Ho T, Crawford TO, LeBel C, Hilt D, Griffin JW: Glial cell line-derived neurotrophic factor alters axon Schwann cell units and promotes myelination in unmyelinated nerve fibers. J Neurosci 2003;15:561–567.
17.
Incesulu A, Nadol JB Jr: Correlation of acoustic threshold measures and spiral ganglion cell survival in severe to profound sensorineural hearing loss: implications for cochlear implantation. Ann Otol Rhinol Laryngol 1998;107:906–911.
18.
Iwase T, Jung CG, Bae H, Zhang M, Soliven B: Glial cell line-derived neurotrophic factor-induced signaling in Schwann cells. J Neurochem 2005;94:1488–1499.
19.
Kanzakii S, Stöver T, Kawamoto K, Prieskorn D M, Altschuler RA, Miller JM, Raphael Y: Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation. J Comp Neurol 2002;454:350–360.
20.
Keithley EM, Ma CL, Ryan AF, Louis JC, Magal E: GDNF protects the cochlea against noise damage. Neuroreport 1998;9:2183–2187.
21.
Kita T, Nakagawa T, Kim TS, Iwai K, Takebayashi S, Akaike A, Ito J: Serofendic acid promotes survival of auditory hair cells and neurons of mice. Neuroreport 2005;16:689–692.
22.
Lefebvre PP, Malgrange B, Staecker H, Moghadass M, Van de Water TR, Moonen G: Neurotrophins affect survival and neuritogenesis by adult injured auditory neurons in vitro. Neuroreport 1994;5:865-868.
23.
Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F: GDNF. A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993;260:1072–1073.
24.
Liu W, Boström M, Kinnefors A, Rask-Andersen H: Unique expression of connexins in the human cochlea. Hear Res 2009;250:55–62.
25.
Love S, Plaha P, Patel NK, Hotton GR, Brooks DJ, Gill SS: Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain. Nat Med 2005;11:703–704.
26.
Malgrange B, Lefebvre P, Van de Water TR, Staecker H, Moonen G: Effects of neurotrophins on early auditory neurons in cell culture. Neuroreport 1996;7:913–917.
27.
Maruyama J, Miller JM, Ulfendahl M: Glial cell line-derived neurotrophic factor and antioxidants preserve the electrical responsiveness of the spiral ganglion neurons after experimentally induced deafness. Neurobiol Dis 2008;29:14–21.
28.
Marzella PL, Clark GM, Shepherd RK, Bartlett PF, Kilpatrick TJ: LIF potentiates the NT-3-mediated survival of spiral ganglia neurones in vitro. Neuroreport 1997;8:1641–1644.
29.
Marzella PL, Gillespie LN, Clark GM, Bartlett PF, Kilpatrick TJ: The neurotrophins act synergistically with LIF and members of the TGF-beta superfamily to promote the survival of spiral ganglia neurons in vitro. Hear Res 1999;138:73–80.
30.
Miller JM, Chi DH, O’Keeffe LJ, Kruszka P, Raphael Y, Altschuler RA: Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int J Dev Neurosci 1997;15:631–643.
31.
Miller JM, Le Prell CG, Prieskorn DM, Wys NL, Altschuler RA: Delayed neurotrophin treatment following deafness rescues spiral ganglion cells from death and promotes regrowth of auditory nerve peripheral processes: effects of brain-derived neurotrophic factor and fibroblast growth factor. J Neurosci Res 2007;85:1959–1969.
32.
Mills CD, Allchorne AJ, Griffin RS, Woolf CJ, Costigan M: GDNF selectively promotes regeneration of injury-primed sensory neurons in the lesioned spinal cord. Mol Cell Neurosci 2007;36:185–194.
33.
Mou K, Hunsberger CL, Cleary JM, Davis RL: Synergistic effects of BDNF and NT-3 on postnatal spiral ganglion neurons. J Comp Neurol 1997;386:529–539.
34.
Naveilhan P, ElShamy WM, Ernfors P: Differential regulation of mRNAs for GDNF and its receptors Ret and GDNFR alpha after sciatic nerve lesion in the mouse. Eur J Neurosci 1997;9:1450–1460.
35.
Paratcha G, Ledda F, Ibáñez CF: The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. J Comp Neurol 2003;28:113–126.
36.
Pirvola U, Hallbook F, Xing-Qun L, Virkkala J, Saarma M, Ylikoski J: Expression of neurotrophins and Trk receptors in the developing, adult, and regenerating avian cochlea. J Neurobiol 1997;33:1019–1033.
37.
Qun LX, Pirvola U, Saarma M, Ylikoski J: Neurotrophic factors in the auditory periphery. Ann NY Acad Sci 1999;28:292–304.
38.
Ramon y Cajal S: Histologie du système nerveux de l’homme et des vertébrés (transl L Azoulay). Madrid, Instituto ‘Ramón y Cajal’, 1909.
39.
Rask-Andersen H, Boström M, Gerdin B, Kinnefors A, Nyberg G, Engstrand T, Miller JM, Lindholm D: Video demonstration of neural progenitor cells in adult human and guinea pig spiral ganglion. Hear Res 2005;203:180–191.
40.
Rask-Andersen H, Tylstedt S, Kinnefors A, Illing R: Synapses on human spiral ganglion cells: a transmission electron microscopy and immunohistochemical study. Hear Res 2000;141:1–11.
41.
Sautter J, Meyer M, Spenger C, Seiler RW, Widmer HR: Effects of combined BDNF and GDNF treatment on cultured dopaminergic midbrain neurons. Neuroreport 1994;6:113–118.
42.
Scheper V, Paasche G, Miller JM, Warnecke A, Berkingali N, Lenarz T, Stöver T: Effects of delayed treatment with combined GDNF and continuous electrical stimulation on spiral ganglion cell survival in deafened guinea pigs. J Neurosci Res 2009;87:1389–1399.
43.
Schuknecht HF: Pathology of the Ear, ed 2. Philadelphia, Lea and Febiger, 1993.
44.
Shepherd RK, Colreavy MP: Surface microstructure of the perilymphatic space: implications for cochlear implants and cell- or drug-based therapies. Arch Otolaryngol Head Neck Surg 2004;130:518–523.
45.
Sjöstrand D, Carlsson J, Paratcha G, Persson B, Ibáñez CF: Disruption of the GDNF binding site in NCAM dissociates ligand binding and homophilic cell adhesion. J Biol Chem 2007;282:12734–12740.
46.
Spoendlin H: Degeneration behaviour of the cochlear nerve. Arch Klin Exp Ohren Nasen Kehlkopfheilkd 1971;200:275–291.
47.
Stöver T, Nam Y, Gong TL, Lomax MI, Altschuler RA: Glial cell line-derived neurotrophic factor (GDNF) and its receptor complex are expressed in the auditory nerve of the mature rat cochlea. Hear Res 2001;155:143–151.
48.
Vieira M, Christensen BL, Wheeler BC, Feng AS, Kollmar R: Survival and stimulation of neurite outgrowth in serum-free culture of spiral ganglion neurons from adult mice. Hear Res 2007;230:17–23.
49.
Webster M, Webster DB: Spiral ganglion neuron loss following organ of Corti loss: a quantitative study. Brain Res 1981;212:17–30.
50.
Wefstaedt P, Scheper V, Lenarz T, Stöver T: Brain-derived neurotrophic factor/glial cell line-derived neurotrophic factor survival effects on auditory neurons are not limited by dexamethasone. Neuroreport 2005;16:2011–2014.
51.
Wei D, Jin Z, Järlebark L, Scarfone E, Ulfendahl M: Survival, synaptogenesis, and regeneration of adult mouse spiral ganglion neurons in vitro. J Neurobiol 2007;67:108–122.
52.
Whitlon DS, Ketels KV, Coulson MT, Williams T, Grover M, Edpao W, Richter CP: Survival and morphology of auditory neurons in dissociated cultures of newborn mouse spiral ganglion. Neuroscience 2006;138:653–662.
53.
Yagi M, Kanzaki S, Kawamoto K, Shin B, Shah PP, Magal E, Sheng J, Raphael Y: Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. J Assoc Res Otolaryngol 2000;1:315–325.
54.
Ylikoski J, Pirvola U, Virkkala J, Suvanto P, Liang XQ, Magal E, Altschuler R, Miller JM, Saarma M: Guinea pig auditory neurons are protected by glial cell line-derived growth factor from degeneration after noise trauma. Hear Res 1998;124:17–26.
55.
Zhao Z, Alam S, Oppenheim RW, Prevette DM, Evenson A, Parsadanian A: Overexpression of glial cell line-derived neurotrophic factor in the CNS rescues motoneurons from programmed cell death and promotes their long-term survival following axotomy. Exp Neurol 2004;190:356–372.
56.
Zheng JL, Stewart RR, Gao WQ: Neurotrophin-4/5, brain-derived neurotrophic factor, and neurotrophin-3 promote survival of cultured vestibular ganglion neurons and protect them against neurotoxicity of ototoxins. J Neurobiol 1995;28:330–340.
57.
Zurn AD, Baetge EE, Hammang JP, Tan SA, Aebischer P: Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurones. Gene Ther 2004;11:746–756.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.